Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Brody, Jonathan
One or more keywords matched the following items that are connected to
Brody, Jonathan
Item Type
Name
Concept
Antimetabolites, Antineoplastic
Academic Article
Implications of enhancer of zeste homologue 2 expression in pancreatic ductal adenocarcinoma.
Academic Article
pp32 (ANP32A) expression inhibits pancreatic cancer cell growth and induces gemcitabine resistance by disrupting HuR binding to mRNAs.
Academic Article
The past, present, and future of biomarkers: a need for molecular beacons for the clinical management of pancreatic cancer.
Academic Article
HuR's role in gemcitabine efficacy: an exception or opportunity?
Academic Article
Is there a role for the quantification of RRM1 and ERCC1 expression in pancreatic ductal adenocarcinoma?
Academic Article
Genomic copy number changes affecting the thymidylate synthase (TYMS) gene in cancer: a model for patient classification to aid fluoropyrimidine therapy.
Academic Article
Evaluating the drug-target relationship between thymidylate synthase expression and tumor response to 5-fluorouracil. Is it time to move forward?
Academic Article
Limits to thymidylate synthase and TP53 genes as predictive determinants for fluoropyrimidine sensitivity and further evidence for RNA-based toxicity as a major influence.
Academic Article
The role of HuR in gemcitabine efficacy in pancreatic cancer: HuR Up-regulates the expression of the gemcitabine metabolizing enzyme deoxycytidine kinase.
Search Criteria
Antimetabolites Antineoplastic